𝔖 Bobbio Scriptorium
✦   LIBER   ✦

AGGRESSIVE NON-HODGKIN'S LYMPHOMA: T-CELL VERSUS B-CELL

✍ Scribed by RAYMOND LIANG; DAVID TODD; FAITH C. S. HO


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
364 KB
Volume
14
Category
Article
ISSN
0278-0232

No coin nor oath required. For personal study only.

✦ Synopsis


This study aimed to define the clinical characteristics, treatment outcome and independent prognostic factors of 144 patients with T-and 357 B-cell non-Hodgkin's lymphomas. Entities with well-defined immunophenotype and clinical characteristics were excluded. Patients with T-cell tumours were younger. T-immunophenotype was associated with more advanced disease and presence of B symptoms. They were also less likely to have bulky disease. Primary nasal lymphomas were usually T-cell while lymphomas arising from the gastrointestinal tract and Waldeyer's ring were mostly B-cell. On univariate analysis, T-immunophenotype was associated with lower CR rate, higher relapse rate and inferior overall survival. On the other hand, multivariate analysis revealed that advanced stage, presence of B symptoms, advanced age, high serum lactate dehydrogenase level and use of non-doxorubicin-containing regimens for induction were associated with poor prognosis. Immunophenotype was not a significant independent prognostic factor.


πŸ“œ SIMILAR VOLUMES


Telomerase activity in B-cell non-Hodgki
✍ Scott A. Ely; Amy Chadburn; C. Mitchell Dayton; Ethel Cesarman; Daniel M. Knowle πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 144 KB πŸ‘ 2 views

## Background: Studies have shown telomerase activity to be present in some b-cell non-hodgkin lymphomas (b-nhls). however, no large studies have assayed telomerase activity in a systematic and quantitative manner. furthermore, the relation between telomerase and proliferation suggested by in vitro

Analysis of PTEN mutations and deletions
✍ Marion P. Butler; Steven I. Wang; R.S.K. Chaganti; Ramon Parsons; Riccardo Dalla πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 166 KB πŸ‘ 2 views

The PTEN gene is involved in 10q23 deletions in several types of cancer, including glioma, melanoma, endometrial and prostate carcinomas. The PTEN gene product is a dual-specificity phosphatase with putative tumor suppressor function. Deletions and rearrangements of 10q22-25 have been reported in Ο³5